Clinical Trial

International SBMA Project (KDA)

Study acronym: KDA
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This project aims at: connecting the existing registries and databases across different countries by comparing the information collected, the administered scales, the biochemical investigations performed; performing a common analysis of fully anonymized data collected in the existing registries and databases by researchers adhering to the study to obtain cross-sectional and longitudinal data. Centres from the following countries have accepted the invitation to join Italy in this project: UK, US, Japan, France, Germany, Korea, Finland, Greece, Canada, Turkey.
Trial Details
NCT Number NCT07443449
Lead Sponsor Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Conditions SBMA, Spinal and Bulbar Muscular Atrophy (SBMA)
Enrollment 700 participants
Start Date 2024-07-29
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-02